<DOC>
	<DOCNO>NCT02098980</DOCNO>
	<brief_summary>There association elevate Type II Diabetes Mellitus ( T2DM ) risk low serum level vitamin D. It important examine whether Vitamin D enhance oral glucose tolerance individual risk develop T2DM . As , hypothesis suggest Vitamin D supplementation ( 4,000 IU/day ) 24 week pre-diabetic individual decrease insulin resistance associate metabolic index link later development T2DM .</brief_summary>
	<brief_title>Nutritional Intervention Type II Diabetes Mellitus Vitamin D Qatar</brief_title>
	<detailed_description>Epidemiologically , association elevate T2DM risk low serum level vitamin D suggest may protect disease improvement insulin sensitivity well secretion reduce chronic inflammation . Although effect show clinical study , study permit inference vitamin D reduce blood glucose attenuate inflammation . Post-prandial glucose sensitive alteration insulin sensitivity . Therefore , rational examine whether vitamin D enhance oral glucose tolerance individual risk develop T2DM elucidate mechanism occur , i.e . via improved insulin sensitivity improve insulin secretion , . Furthermore , identify distinct proteomics-based signature use distinguish responder supplementation non-responders critical define base inter-individual variation response effect vitamin D prevention T2DM . Identification proteomics-based signature enable u tailor alternative preventive measure adjust vitamin D dose non-responders , lead effective precise intervention protocol .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>male nonpregnant , nonlactating female , age 1875 volunteered participate signing consent form BMI ˂ 40kg/ m2 serum 25 ( OH ) vitamin D3 ( 25 ( OH ) D ) concentration ˂75nmol/L fast serum glucose &lt; 7.0 mmol/L HOMA insulin resistance index ≥1.3 presence ONE OR MORE following risk factor type 2 diabetes : high BMI ( &gt; 23 ) high waist circumference accord IDF ethnic specific value non Caucasian ( female &gt; 80cm ; male &gt; 90cm ) family history diabetes firstdegree relative ( parent sibling ) previous history gestational diabetes history high blood glucose , high triglyceride and/or low HDL cholesterol fast serum glucose ≥7.0mmol/L history renal failure liver disease serum urea creatinine &gt; 1.8 time upper limit normal ( ULN ) serum aspartate alanine transaminase ( AST , ALT ) &gt; 1.5 time ULN current use drug drug treat diabetes influence glucose metabolism medical surgical event require hospitalization within 3 month randomization presence condition affect nutrient absorption</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>